Immunity and Infections
HMO help support immunity. Clinical studies have reported a relationship between HMO and immune outcomes in infants. HMO are reported to support an infant’s immune system. HMO may help reduce the risk of infection. HMO may help reduce the risk of certain infections in infants.
Addition of 2’FL/2’FL + LNnT to infant formula* has been clinically reported to help support the immune system. Infant formula containing 2’FL/2’FL + LNnT may help to reduce the incidence of certain (parent-reported) infections and illnesses. Infant formula containing 2’FL + LNnT has been reported to reduce the incidence of (parent reported) respiratory tract infections, anti-fever medication, and antibiotics. Clinical data suggest infant formula with 2’FL/2’FL + LNnT help support immunity.
*HMO in infant formula is dependent on the levels of 2’FL +/- LNnT supplemented into the formula.